Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Feldheim

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
International Journal of Molecular Sciences|July 28, 2022
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of PatientsJonas Feldheim, David Wend, Mara J Lauer, et al.
Cancers|August 26, 2023
Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 PandemicJonas Feldheim, Teresa Schmidt, Christoph Oster, et al.
International Journal of Molecular Sciences|May 14, 2022
Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like CellsJonas Feldheim, Almuth F Kessler, Julia J Feldheim, et al.
Neuro-Oncology Advances|August 7, 2023
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastomaTeresa Schmidt, Sarina Agkatsev, Jonas Feldheim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival DataChristoph Oster, Lukas Kessler, Tobias Blau, et al.
Neuro-Oncology Advances|January 7, 2026
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?Christoph Oster, Pia Reineck, Teresa Schmidt, et al.
Neuro-Oncology Advances|October 26, 2022
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed <i>MGMT</i> promoter methylated <i>IDH</i> wildtype glioblastomaLazaros Lazaridis, Elisabeth Bumes, Dorothee Cäcilia Spille, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Molecular Sciences|July 28, 2022
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of PatientsJonas Feldheim, David Wend, Mara J Lauer, et al.
Cancers|August 26, 2023
Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 PandemicJonas Feldheim, Teresa Schmidt, Christoph Oster, et al.
International Journal of Molecular Sciences|May 14, 2022
Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like CellsJonas Feldheim, Almuth F Kessler, Julia J Feldheim, et al.
Neuro-Oncology Advances|August 7, 2023
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastomaTeresa Schmidt, Sarina Agkatsev, Jonas Feldheim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival DataChristoph Oster, Lukas Kessler, Tobias Blau, et al.
Neuro-Oncology Advances|January 7, 2026
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?Christoph Oster, Pia Reineck, Teresa Schmidt, et al.
Neuro-Oncology Advances|October 26, 2022
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed <i>MGMT</i> promoter methylated <i>IDH</i> wildtype glioblastomaLazaros Lazaridis, Elisabeth Bumes, Dorothee Cäcilia Spille, et al.
Pageof 2